Zydus Cadila launches cancer drug

MUMBAI: Pharma major Zydus Cadila on Friday said it has launched a drug, Nudoxa, which can be used in the treatment of cancer.

Zydus Cadila has introduced a Novel Drug Delivery System (NDDS) product used in the treatment of various cancer, the company said in a filling to the Bombay Stock Exchange.
   
Nudoxa is used in chemotherapy, which is a common mode for treatment of cancer. "Nudoxa addresses the need for a drug that has reduced toxicity and side effects," Cadila said.

The drug is particularly used for treating breast and ovarian cancer, the company said.
   
Nudoxa with its unique drug delivery system is a breakthrough in cancer therapy as it offers the benefits of Pegylaled-liposomal doxorubiein, which is used as an oncology drug, Cadila added.
   
However, Pegylated-liposomal doxorubicin causes side effects like skin eruptions.
   
Nudoxa has patent rights in India and South Africa, and has also filed for patents in EU, the US and Japan.
   
Marketed by Zydus Biogen, the drug is manufactured by Zydus-BSV Pharma Pvt Ltd, the joint venture company of Zydus Cadila and Bharat Serums and Vaccines Pvt Ltd.
   
Shares of Cadila Healthcare were trading at Rs 249.50, down 0.30 per cent on the BSE.